- Display 15 Products per page
In Vitro Diagnostics Business Outlook, 2024 (6 updates)
Published: July 5, 2024 | Price: $4,995.00 – $9,995.00
In Vitro Diagnostics Business Outlook is a bimonthly publication with six issues annually. In Vitro Diagnostics Business Outlook offers information and data that you cannot get anywhere else, including: Market data and forecasts (growth rates, market size, market share, etc.) to identify growth opportunities A comprehensive view of the IVD market with test categories covered and company briefs M&A activities, selected partnerships & collaborations, partnership deals, and more Industry & region watch to help tailor strategies Analysis of news and events and reporting on...
In Vitro Diagnostic (IVD) Trends and Market Update: March 2024
Published: March 27, 2024 | Price: $5,000.00 – $10,500.00
Diagnostic testing has become a fundamental aspect of healthcare, aiding physicians in diagnosing conditions and determining treatments. Despite a decline in COVID-19 testing affecting total revenues, core diagnostic segments have generally experienced growth. Factors such as new products, changes in global health spending, regulatory shifts, and disease trends contribute to a constantly changing market, yet one that remains resilient. Key growing segments attracting industry attention include next-generation sequencing (NGS), personalized medicine, and mass spectrometry. Immunochemistry, point-of-care (POC) testing, and molecular...
In Vitro Diagnostic (IVD) Trends and Market Update: November 2023
Published: November 7, 2023 | Price: $3,750.00 – $7,500.00
In vitro diagnostic (IVD) testing is getting back to regular business and continues to be a driving force in the practice of medicine. It has gone from helping the physician to diagnose illness to providing the physician with invaluable information on treatments such as precision medicine. COVID-19 testing continues to decline but is still a factor in total revenues for 2023. New products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors...
The Market for In Vitro Diagnostic (IVD) Tests in Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela and Other Nations)
Published: January 23, 2023 | Price: $5,000.00 – $10,000.00
This report, The Market for In Vitro Diagnostic (IVD) Tests in Latin America, focuses on the market for reagents and instruments in the most important countries of the region. Argentina, Brazil, Chile, Colombia, Mexico, Peru and Venezuela are singled out for a deeper level of analysis; the countries of Bolivia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Guyana, Haiti, Honduras, Nicaragua, Panama, Paraguay, and Uruguay were also considered to provide a complete overview of the region. Combined, these...
In Vitro Diagnostics (IVD) in Malaysia, Singapore and Indonesia, 2022
Published: October 18, 2022 | Price: $5,000.00 – $10,000.00
The Asia Pacific (APAC) region is a fast-growing in vitro diagnostics (IVD) market, which is witnessing increasing focus by leading global players in the market. Southeast Asia has been identified as one of the key regions in APAC region offering significant opportunities for IVD companies. This report focuses on three IVD markets in Southeast Asia: Malaysia, Indonesia, and Singapore. These three countries together represent a fast-growing geographic region offering significant opportunity for IVD companies. The total population of these three...
United States Market for In Vitro Diagnostic (IVD) Tests, 4th Edition
Published: October 6, 2022 | Price: $5,000.00 – $10,000.00
The U.S. market dominates the IVD industry AND remains the core geographical IVD market in the world. Yet this major multi-billion-dollar IVD market is in a state of flux, trying to manage a myriad of issues, all of which collide with a huge system that costs more than any other in the world. This latest report from Kalorama Information, United States Market for In Vitro Diagnostic (IVD) Tests, 4th Edition, discusses the trends shaping the present and future of the IVD...
The Market for Contract Manufacturing in In Vitro Diagnostics (IVD)
Published: September 2, 2022 | Price: $0.00 – $12,000.00
The global in vitro diagnostic (IVD) industry incorporates a sizable contract manufacturing segment that supplies a full range of reagents and test kits, instruments and systems, and testing accessories. Already a multi-billion dollar market, this segment is well positioned to generate favorable long-term growth, as detailed in this report, The Market for Contract Manufacturing in IVD. Most leading worldwide of producers of proprietary IVD systems will increase their reliance on outside contractors as a cost-effective means to: expand existing product...
In Vitro Diagnostics (IVD) in India
Published: June 29, 2022 | Price: $5,000.00 – $10,000.00
This new report from Kalorama Information is designed to provide an overview of the IVD market in India and its influences. The focus is on the IVD discipline including reagents, consumables, calibrators and controls of the following sub-segments: Clinical Chemistry: routine lab testing; substrates, enzymes, homogeneous immunoassays, proteins, ISE (non-POC), HBA1c (non-POC). Includes urinalysis and blood chemistry testing. Immunoassays: hormones and thyroid function, tumor markers, allergy, anemia, neonatal tests, prenatal tests, interleukins, PCT, toxicology and common infectious diseases (HIV, hepatitis,...
In Vitro Diagnostics (IVD) in the Middle East and Africa
Published: May 27, 2022 | Price: $5,000.00 – $10,000.00
There has been an increasing standard of living in the Middle East and Africa due to higher national income. This has contributed to a higher incidence of heart disease - high blood pressure, high cholesterol and high blood sugar. In fact, the Middle East/Africa region is one of the higher areas for heart disease which has prompted more individuals being admitted to the hospital. This has caused an uptick in the demand for diagnostic testing devices and medical devices. This...
World Market for Blood Screening
Published: January 5, 2022 | Price: $3,750.00 – $7,500.00
This new Kalorama Information report, World Market for Blood Screening, focuses on the evolving, multibillion dollar global blood screening market. Blood screening is a medical process that scans the blood for infectious diseases or conditions. In developed nations, donated blood is screened for various pathogens. It is a mature market; however, growth comes from new technologies, increased volume and increased testing in developing nations. Blood screening testing’s primary objectives are to monitor the appearance of newly discovered infectious agents in...
In Vitro Diagnostics (IVD) Market in China, 2021
Published: September 29, 2021 | Price: $4,000.00 – $8,000.00
As an in vitro diagnostics (IVD) market, China trails only the populous, developed economy markets of the United States, western European countries, and Japan. The country and its healthcare system are confronted by challenges shared by less developed countries, but also burdens common among developed middle-income and affluent countries such as diabetes, cardiovascular disease, and diseases of aging. China as an IVD market opportunity is defined by its standing next to other populous countries with demonstrated economic promise for over...
United States Market for In Vitro Diagnostic (IVD) Tests
Published: June 7, 2021 | Price: $4,000.00 – $8,000.00
The U.S. market dominates the IVD industry AND remains the core geographical IVD market in the world. Yet this major multi-billion-dollar IVD market is in a state of flux, trying to manage a myriad of issues, all of which collide with a huge system that costs more than any other in the world. COVID-19 had a profound effect on the IVD diagnostic industry – some segments exploded and others languished. At this point in time, it is hard to predict...
The World Market for HbA1c Tests
Published: October 17, 2019 | Price: $5,000.00 – $10,000.00
Given its effectiveness in detecting and monitoring treatment of diabetes, HbA1c has become a high-growth and highly competitive market in IVD testing. Globally, a growing amount of dollars is being spent annually on HbA1c testing, for both professional and self-testing. Over a dozen companies produce analyzers, reagents, workstations, and point-of-care (POC) devices that run HbA1c tests. A major contributing factor to growth is the growing availability of HbA1c testing both at the professional level and at the self-testing level. Kalorama’s...